Search Results 41-50 of 17046 for ulcerative%20colitis
... ulcerative colitis (UC). RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A ...
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...
If you're taking tofacitinib for ulcerative colitis, don't stop taking the medicine without first talking with a healthcare professional. Biologics. Biologics ...
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...
May 14, 2010. Dear Mayo Clinic: When I quit smoking cigarettes four years ago, I discovered I have ulcerative colitis. After a few years of only moderate ...
This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.
The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...
About this study. The purpose of this study is to determine safety and tolerability of orally delivered R-3750 in mild to moderate patients with ulcerative ...
Ulcerative Colitis (UC) is a chronic inflammatory disease affecting the mucosal lining of the colon and rectum and the incidence is increasing, ...
Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.